ATE171218T1 - Rekombinanter varicella-zoster-virus-vektor - Google Patents
Rekombinanter varicella-zoster-virus-vektorInfo
- Publication number
- ATE171218T1 ATE171218T1 AT92303705T AT92303705T ATE171218T1 AT E171218 T1 ATE171218 T1 AT E171218T1 AT 92303705 T AT92303705 T AT 92303705T AT 92303705 T AT92303705 T AT 92303705T AT E171218 T1 ATE171218 T1 AT E171218T1
- Authority
- AT
- Austria
- Prior art keywords
- recombinant
- virus
- zoster virus
- virus vector
- recombinant varicella
- Prior art date
Links
- 241000701085 Human alphaherpesvirus 3 Species 0.000 title abstract 3
- 241000700605 Viruses Species 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 229940039227 diagnostic agent Drugs 0.000 abstract 2
- 239000000032 diagnostic agent Substances 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 201000006082 Chickenpox Diseases 0.000 abstract 1
- 241000700721 Hepatitis B virus Species 0.000 abstract 1
- 206010046980 Varicella Diseases 0.000 abstract 1
- 208000002672 hepatitis B Diseases 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 229940031348 multivalent vaccine Drugs 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/25—Varicella-zoster virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16741—Use of virus, viral particle or viral elements as a vector
- C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Analytical Chemistry (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3191340A JP3026029B2 (ja) | 1991-04-26 | 1991-04-26 | 組換え水痘ウイルスとその作製法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE171218T1 true ATE171218T1 (de) | 1998-10-15 |
Family
ID=16272939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92303705T ATE171218T1 (de) | 1991-04-26 | 1992-04-24 | Rekombinanter varicella-zoster-virus-vektor |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US5653976A (de) |
| EP (1) | EP0510996B1 (de) |
| JP (1) | JP3026029B2 (de) |
| KR (1) | KR100224331B1 (de) |
| AT (1) | ATE171218T1 (de) |
| AU (1) | AU659449B2 (de) |
| CA (1) | CA2066998C (de) |
| DE (1) | DE69226980T2 (de) |
| DK (1) | DK0510996T3 (de) |
| ES (1) | ES2120989T3 (de) |
| TW (1) | TW210354B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9226768D0 (en) * | 1992-12-23 | 1993-02-17 | Smithkline Beecham Biolog | Vaccines |
| CA2176929C (en) * | 1993-11-19 | 2002-04-30 | Nigel Maurice Harford | Vaccine against mumps containing a jeryl-lynn virus strain |
| FR2719056B1 (fr) * | 1994-04-20 | 1996-09-06 | Rhone Merieux | Herpesvirus transformés pour exprimer gD in vitro. |
| DE69729996T2 (de) * | 1996-05-15 | 2005-08-25 | The Research Foundation For Microbial Diseases Of Osaka University, Suita | Methode zur identifizierung von attenuiertem varicella virus vom stamm oka oder von einem davon abstammenden stamm |
| ES2273482T3 (es) | 1998-03-09 | 2007-05-01 | Glaxosmithkline Biologicals S.A. | Composiciones de vacunas combinadas. |
| EP1074624B1 (de) * | 1999-02-25 | 2005-04-13 | The Research Foundation for Microbial Diseases of Osaka University | Gen 62 des attenuierten windpocken-virusstammes oka und verfahren zur identifikation eines attenuierten, lebenden windpockenvirusstammes unter verwendung dieses genes. |
| US6528066B1 (en) * | 1999-09-14 | 2003-03-04 | University Of Iowa Research Foundation | Variant varicella-zoster viruses and methods of use |
| UA79735C2 (uk) | 2000-08-10 | 2007-07-25 | Глаксосмітклайн Байолоджікалз С.А. | Очищення антигенів вірусу гепатиту b (hbv) для використання у вакцинах |
| CA2630770A1 (en) * | 2005-11-24 | 2007-05-31 | The Research Foundation For Microbial Diseases Of Osaka University | Recombinant polyvalent vaccine |
| CN115768892A (zh) | 2020-03-09 | 2023-03-07 | 戴纳瓦克斯技术公司 | 包含tlr9激动剂的带状疱疹疫苗 |
| WO2025199215A1 (en) * | 2024-03-19 | 2025-09-25 | Mayo Foundation For Medical Education And Research | Varicella-zoster viruses and methods and materials for using varicella-zoster viruses |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0182442B2 (de) * | 1978-12-22 | 1996-04-03 | Biogen, Inc. | Rekombinante DNS-Moleküle und Verfahren zur Herstellung derselben |
| JPH0745514B2 (ja) * | 1985-08-20 | 1995-05-17 | 武田薬品工業株式会社 | 新規蛋白質およびその製造法 |
| NZ220645A (en) * | 1986-06-20 | 1989-10-27 | Merck & Co Inc | Modified varicella-zoster virus and its cultivation |
| US4963483A (en) * | 1987-10-13 | 1990-10-16 | Merck & Co., Inc. | Method for producing hepatitis B virus proteins in yeast |
| NZ229260A (en) * | 1988-06-03 | 1994-02-25 | Merck & Co Inc | Hepatitis b virus, expression cassette for pre-s domain, host cells and |
-
1991
- 1991-04-26 JP JP3191340A patent/JP3026029B2/ja not_active Expired - Fee Related
-
1992
- 1992-04-24 EP EP92303705A patent/EP0510996B1/de not_active Expired - Lifetime
- 1992-04-24 AT AT92303705T patent/ATE171218T1/de not_active IP Right Cessation
- 1992-04-24 ES ES92303705T patent/ES2120989T3/es not_active Expired - Lifetime
- 1992-04-24 DE DE69226980T patent/DE69226980T2/de not_active Expired - Lifetime
- 1992-04-24 DK DK92303705T patent/DK0510996T3/da active
- 1992-04-24 CA CA002066998A patent/CA2066998C/en not_active Expired - Fee Related
- 1992-04-25 KR KR1019920007062A patent/KR100224331B1/ko not_active Expired - Fee Related
- 1992-04-27 AU AU15214/92A patent/AU659449B2/en not_active Ceased
- 1992-05-22 TW TW081104011A patent/TW210354B/zh active
-
1994
- 1994-11-15 US US08/340,880 patent/US5653976A/en not_active Expired - Lifetime
-
1997
- 1997-03-13 US US08/816,262 patent/US5849476A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US5849476A (en) | 1998-12-15 |
| EP0510996B1 (de) | 1998-09-16 |
| AU1521492A (en) | 1992-10-29 |
| KR920019927A (ko) | 1992-11-20 |
| AU659449B2 (en) | 1995-05-18 |
| JP3026029B2 (ja) | 2000-03-27 |
| DK0510996T3 (da) | 1999-06-14 |
| ES2120989T3 (es) | 1998-11-16 |
| JPH06189752A (ja) | 1994-07-12 |
| US5653976A (en) | 1997-08-05 |
| KR100224331B1 (ko) | 1999-10-15 |
| TW210354B (de) | 1993-08-01 |
| CA2066998C (en) | 2000-05-23 |
| DE69226980T2 (de) | 1999-05-12 |
| EP0510996A1 (de) | 1992-10-28 |
| CA2066998A1 (en) | 1992-10-27 |
| DE69226980D1 (de) | 1998-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69737886D1 (de) | Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays | |
| ATE171218T1 (de) | Rekombinanter varicella-zoster-virus-vektor | |
| ATE468858T1 (de) | Chimäre impfstoffe gegen flaviviren | |
| DE69125925D1 (de) | Rekombinante herpes simplex virus impfstoffe und methoden | |
| RU93058449A (ru) | Hcv геномные последовательности для диагностических и терапевтических целей | |
| RU93058614A (ru) | Мутант вируса герпеса, композиции, диагностические наборы, способы определения инфекции | |
| DE69426051D1 (de) | Infektiösen Bronchitis Virus 4/91 enthaltender Geflügel-Impfstoff | |
| MY103575A (en) | Cannie coronavirus vaccine | |
| SG55095A1 (en) | Viruses and their use as a vaccine against feline infectious peritonitis virus disease | |
| ATE412055T1 (de) | Impfstoffe gegen viren der marek krankheit (mdv) und varicella zoster virus. | |
| ATE193726T1 (de) | Spezifische nukleotidsequenz enthaltender masernvirusvakzinstamm und verfahren zu seiner absoluten identifizierung | |
| DK0507179T3 (da) | Equine herpesvira (EHV), der indeholder fremmed | |
| ATE223492T1 (de) | Mutanten des infektiösen rinder rhinotracheitis- virus und impfstoffe | |
| EP0822980A4 (de) | Rekombinantes infektiöses laryngotracheitisvirus und dessen verwendung | |
| ES2132330T3 (es) | Vacuna para la proteccion de caballos frente a la infeccion por el virus del herpes equino. | |
| AR031599A1 (es) | Vacunas para el virus herpes equino tipo 1: virus que hospeda mutaciones dentro del gen inmediato precoz | |
| TH13474A (th) | รีคอมบิแนนท์ varicella - zoster virus และขบวนการสร้าง | |
| WO1997040166A3 (en) | Simian-human hav having a chimeric 2c protein | |
| ATE46264T1 (de) | Thymidinkinase-negativ-temperaturbestaendiger rinder herpes-virus-1-mutant als vakzin gegen infektioese rinder-rhinotracheitis. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |